Histopathological biomarkers for predicting the tumour accumulation of nanomedicines.
May JN, Moss JI, Mueller F, Golombek SK, Biancacci I, Rizzo L, Elshafei AS, Gremse F, Pola R, Pechar M, Etrych T, Becker S, Trautwein C, Bülow RD, Boor P, Knuechel R, von Stillfried S, Storm G, Puri S, Barry ST, Schulz V, Kiessling F, Ashford MB, Lammers T.
May JN, et al. Among authors: schulz v.
Nat Biomed Eng. 2024 Apr 8. doi: 10.1038/s41551-024-01197-4. Online ahead of print.
Nat Biomed Eng. 2024.
PMID: 38589466